Modiodal (Modafinil)

Modafinil primarily blocks dopamine reuptake, raising extracellular dopamine levels, and also stimulates orexin and histamine pathways in the hypothalamus. These combined actions enhance cortical arousal and sustain alertness without causing the pronounced stimulation seen with traditional stimulants.

The appropriate dose of Modiodal is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Modiodal in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To request Modiodal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Modiodal (modafinil) differs from traditional stimulants such as methylphenidate by having a lower potential for cardiovascular stimulation and abuse. Its mechanism focuses on dopamine reuptake inhibition and orexin activation, offering wakefulness with a generally smoother side‑effect profile.

Store Modiodal at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight to maintain potency throughout the shelf life.

Modiodal is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber regarding timing and any dietary considerations.

Serious adverse reactions, though rare, include severe skin reactions such as Stevens‑Johnson syndrome, cardiovascular events like chest pain or arrhythmias, and psychiatric disturbances including hallucinations or severe mood changes. Immediate medical attention is required if any of these occur.

Modiodal is contraindicated in individuals with known hypersensitivity to modafinil or any of its excipients. Caution is advised for patients with uncontrolled hypertension, significant cardiac disease, severe hepatic impairment, or a history of psychiatric disorders, and it should be avoided in pregnancy unless clearly needed.